P.068 Real world experience with Fingolimod in Canada
نویسندگان
چکیده
منابع مشابه
The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis.
Fingolimod is a new and efficient treatment for multiple sclerosis (MS). The drug administration requires special attention to the first dose, since cardiovascular adverse events can be observed during the initial six hours of fingolimod ingestion. The present study consisted of a review of cardiovascular data on 180 patients with MS receiving the first dose of fingolimod. The rate of bradycard...
متن کاملLong-term safety and real-world effectiveness of fingolimod in relapsing multiple sclerosis
With a growing number of disease-modifying therapies becoming available for relapsing multiple sclerosis, there is an important need to gather real-world evidence data regarding long-term treatment effectiveness and safety in unselected patient populations. Although not providing as high a level of evidence as randomized controlled trials, and prone to bias, real-world studies from observationa...
متن کاملA real world experience with fingolimod in active RRMS patients naïve to second-line agents: a 2 years, intention-to-treat, observational, single center study
Background: Fingolimod is approved by EMA as a second-line treatment for relapsing-remitting multiple sclerosis (RRMS). Experience with fingolimod in real life is still limited. Aim of our study was to report data on fingolimod effectiveness in a real life cohort of Italian active RRMS patients, naïve to second-line agents, followed for 2 years. Fingolimod was a part of the patients’ regular tr...
متن کاملGrowth Hormone Treatment in Turner's Syndrome: A Real World Experience
OBJECTIVE Short stature is a universal clinical feature of Turner's syndrome (TS). Growth failure begins in fetal life, and adults with TS are on an average 20 cm shorter than the normal female population. Since there is a paucity of data from India regarding the effect of growth hormone (GH) on TS patients, we retrospectively analyzed the data of TS patients who are on GH treatment. METHODS ...
متن کاملHeartWare ventricular assist device experience in the real world.
We congratulate Wu et al. [1] for sharing their experience with the HeartWare ventricular assist device (HVAD), which is the largest published series so far. They were successful in demonstrating improvement not only in haemodynamic parameters but also in renal and liver function after device implantation. In comparison with previously published multicentre trials and single-centre experiences ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
سال: 2017
ISSN: 0317-1671,2057-0155
DOI: 10.1017/cjn.2017.152